LI
ABBV icon

LMCG Investments’s AbbVie ABBV Stock Holding History

LMCG Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2M Buy
139,806
+3,312
+2% +$713K 1.88% 9
2026
Q1 		$29.7M Sell
136,494
-2,882
-2% -$639K 1.77% 11
2025
Q4 		$31.8M Sell
139,376
-3,864
-3% -$880K 1.82% 8
2025
Q3 		$33.2M Sell
143,240
-3,007
-2% -$612K 1.95% 8
2025
Q2 		$27.1M Sell
146,247
-16,540
-10% -$3.07M 1.7% 9
2025
Q1 		$34.1M Sell
162,787
-4,469
-3% -$869K 2.26% 6
2024
Q4 		$29.7M Sell
167,256
-4,592
-3% -$844K 1.82% 8
2024
Q3 		$33.9M Sell
171,848
-203
-0.1% -$37.9K 2.04% 6
2024
Q2 		$29.5M Buy
172,051
+3,155
+2% +$523K 1.72% 7
2024
Q1 		$30.8M Sell
168,896
-1,386
-0.8% -$239K 1.81% 6
2023
Q4 		$26.4M Buy
170,282
+2,983
+2% +$435K 1.63% 6
2023
Q3 		$24.9M Sell
167,299
-2,248
-1% -$330K 1.68% 6
2023
Q2 		$22.8M Buy
169,547
+23,315
+16% +$3.42M 1.48% 8
2023
Q1 		$23.3M Sell
146,232
-3,891
-3% -$595K 1.55% 6
2022
Q4 		$24.3M Sell
150,123
-1,978
-1% -$303K 1.69% 7
2022
Q3 		$20.4M Sell
152,101
-5,703
-4% -$818K 1.49% 8
2022
Q2 		$24.2M Sell
157,804
-1,720
-1% -$263K 1.67% 6
2022
Q1 		$25.9M Buy
+159,524
New +$23.2M 1.5% 8
2015
Q3 		$10.7M Sell
196,830
-1,995
-1% -$130K 0.23% 168
2015
Q2 		$13.4M Sell
198,825
-4,269
-2% -$279K 0.29% 122
2015
Q1 		$11.9M Sell
203,094
-2,746
-1% -$166K 0.25% 165
2014
Q4 		$13.5M Sell
205,840
-877
-0.4% -$55.3K 0.29% 131
2014
Q3 		$11.9M Sell
206,717
-1,758
-0.8% -$97.6K 0.27% 157
2014
Q2 		$11.8M Sell
208,475
-16,215
-7% -$851K 0.25% 160
2014
Q1 		$11.5M Sell
224,690
-3,090
-1% -$156K 0.26% 158
2013
Q4 		$12M Sell
227,780
-8,958
-4% -$440K 0.26% 157
2013
Q3 		$10.6M Sell
236,738
-9,242
-4% -$410K 0.26% 144
2013
Q2 		$10.2M Buy
+245,980
New +$10.8M 0.27% 136

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

LMCG Investments's ABBV Position: Q2 2026 in Review

LMCG Investments increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $713K and bringing the position to 139,806 shares worth $35.2M. The position accounts for 1.88% of the portfolio, ranked #9.

LMCG Investments first reported a position in ABBV in Q2 2013 and has held it in 28 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LMCG Investments held 139,806 shares of AbbVie worth $35.2M as of Q2 2026.
  • LMCG Investments bought 3,312 AbbVie shares in Q2 2026, an estimated $713K.
  • AbbVie made up 1.88% of LMCG Investments's portfolio in Q2 2026, its #9 holding.
  • LMCG Investments first reported a position in AbbVie in Q2 2013 and has held it in 28 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.